Terminology Service < Semantic Lookup Platform

All terms in NCIT

Label	Id	Description
Ventricular Tachycardia	NCIT_C50802	[A disorder characterized by an electrocardiographic finding of three or more consecutive complexes of ventricular origin with a rate greater than a certain threshold (100 or 120 beats per minute are commonly used). The QRS complexes are wide and have an abnormal morphology. (CDISC)]
Imipenem Anhydrous	NCIT_C146984
Beta-Lactam Antibiotic	NCIT_C260	[A compound with a four member amide ring (beta-lactam), where one member is the amide nitrogen and another is the carbonyl carbon, with bactericidal activity. Beta-lactam antibiotics act by disrupting the synthesis of the peptidoglycan layer of the bacterial cell wall.]
Musculoskeletal System Disorder	NCIT_C107377	[A category of diseases that involve muscles and bones.]
Connective and Soft Tissue Disorder	NCIT_C27574	[A non-neoplastic or neoplastic disorder that affects the connective and soft tissue.]
Connective and Soft Tissue	NCIT_C12964	[The supporting connective tissue of an organ.]
AJCC Cancer Staging Manual 8th Edition	NCIT_C146985	[The 8th edition of the criteria developed by the American Joint Committee on Cancer (AJCC), implemented in 2018, used for the classification and staging of neoplastic diseases.]
Thyme Oil	NCIT_C107367	[The essential oil of Thymus vulgaris. Thyme oil is used for its antibiotic and antifungal activities.]
Brief Protocol Title	NCIT_C132345	[The short, descriptive name for the protocol.]
Turmeric Oil	NCIT_C107368	[The oil extracted from the rhizomes of Curcuma longa. Turmerica oil is used for aromatherapy and can be used for its antioxidant and anti-inflammatory properties.]
Official Protocol Title	NCIT_C132346	[The formal, descriptive name of the protocol.]
Turpentine Oil	NCIT_C107369	[The oily fluid obtained by the distillation of various pine resins. Turpentine is used as a solvent, industrial ingredient, and medicinal ingredient.]
Protocol Amendment	NCIT_C132347	[A written description of a change(s) to, or formal clarification of, a protocol. (ICH E6)]
Amendment	NCIT_C41200	[A change in a document made by correction, adding, substituting or omitting a certain part. Amendments are the mechanism of changes introduction, further development and improvement of previously submitted or approved clinical study protocols and proposals.]
Registry Protocol Identifier	NCIT_C132348	[A unique code, which is assigned by the clinical trial registry, that identifies a specific protocol.]
Hyaluronic Acid Binding	NCIT_C20758	[Hyaluronic Acid Binding involves a biophysical interaction between a biological molecule, such as a protein, and hyaluronic acid, a linear glycosaminoglycan of repeating disaccharide units, in proteoglycans.]
Schedule of Activities	NCIT_C132349	[A planned list of clinical trial activities to include interventions, assessments, and study administrative activities.]
Schedule	NCIT_C25211	[An ordered list of times at which things are planned to occur.]
ACRBP Gene	NCIT_C20754	[This gene plays a role in the compartmentalization of acrosomal matrix and is associated with a number of cancers.]
Gastric Mucus Secretion Induction	NCIT_C41563	[Gastric Mucus Secretion Induction involves stimulation of mucus release from gastric cells into the lumen of the stomach. Stimulation promotes mucous protection and lubrication of the stomach.]